Clinical trials: Rosacea, Erythematotelangiectatic
Rosacea, Erythematotelangiectatic
Metronidazole SC Penetrance With Moisturizers
Topical metronidazole is a widely used first line treatment for erythemotelangiectatic and inflammatory rosacea. Commonly, a moisturizer is also used to restore the skin barrier and reduce inflammation.
- Trial name
- NCT06434519
- Testing
- Metronidazole cream, Cetaphil moisturizer, CeraVe moisturizer
- Where
- United States
- Volunteers
- 21 people, healthy volunteers welcome
- Sponsor
- Duke University
Rosacea, Papulopustular, Rosacea, Erythematotelangiectatic
Rosacea Radiofrequency Microneedling
There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for…
- Trial name
- NCT06801717
- Testing
- KTP Laser Therapy, Radiofrequency microneedling
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Miami
Rosacea
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
This is a Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized Phase II trial, comparing the effect of twice daily B244 application for 8 weeks vs. vehicle application on treatment of mild to moderate rosacea.
- Trial name
- NCT03590366
- Testing
- B244, Vehicle
- Where
- 9 sites in United States
- Volunteers
- 140 people
- Sponsor
- AOBiome LLC
Rosacea Subtype 1 (Erythematotelangiectatic)
Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)
Rossoseq™ is registered for the treatment of inflammatory skin conditions. Rosacea is one such inflammatory skin disorder that has not been studied yet for the use of Rossoseq™.
- Trial name
- NCT01666509
- Testing
- Rossoseq™
- Where
- 4 sites in Germany
- Volunteers
- 61 people
- Sponsor
- PBB Entrepreneur Ltd.
Rosacea, Rosacea, Erythematotelangiectatic
Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea
A single arm, pilot study among individuals with rosacea and at least moderate flushing or rednesss will be enrolled in a 4-week trial of taVNS.
- Conditions
- Rosacea, Rosacea, Erythematotelangiectatic, Flushing
- Trial name
- NCT07600424
- Testing
- Transaricular vagus nerve stimulation (taVNS)
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Brigham and Women's Hospital
Rosacea, Erythematotelangiectatic, Rosacea Subtype 1 (Erythematotelangiectatic)
Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy
The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels associated with erythematotelangiectatic rosacea.
- Trial name
- NCT07521462
- Testing
- Dermocosmetic tested product, Vascular laser treatment
- Where
- France
- Volunteers
- 50 people
- Sponsor
- ISISPHARMA
Erythematotelangiectatic Rosacea
Combination Therapy for the Treatment of Rosacea
The purpose of this study is to determine the efficacy of calcium dobesilate in combination with pulsed dye laser for the treatment of rosacea.
- Trial name
- NCT00945373
- Testing
- calcium dobesilate, pulsed dye laser
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Ellen Marmur
Rosacea
Atralin Gel for the Treatment of Rosacea
Erythematotelangiectatic rosacea is a type of rosacea that causes a red face often with frequent flushing, topical sensitivity and prominent blood vessels.
- Trial name
- NCT01125930
- Testing
- vehicle gel, Atralin gel
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- Lisa E. Maier